Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE).
Marwan FakihWael HarbDaruka MahadevanHani BabikerJordan BerlinTom LillieDavid KrigeJo CarterChris CoxMinesh PatelLola ParfittMark PowellLee RosenPublished in: Journal for immunotherapy of cancer (2023)
NCT02636036.